COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. to Present at the Biotech Showcase™ 2018
03/01/2018
LAS VEGAS, Jan. 03, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. , (OTCQB:CVSI) (the "Company," "CV Sciences," "our" or "we"), preeminent supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil and [...]
Spark Therapeutics Announces First-of-their-kind Programs to Improve Patient Access to LUXTURNA™ (voretigene neparvovec-rzyl), a One-time Gene Therapy Treatment
03/01/2018
Company offers outcomes-based rebates and an innovative contracting model that support patient access in the U.S. while aiming to reduce risk and financial burden for payers and treatment centers Harvard Pilgrim and [...]
Bellerophon Announces First Patient Enrolled in Phase 2b Study Evaluating INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
03/01/2018
WARREN, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced that the first patient has been randomized into a Phase 2b study [...]
Agritek Holdings, Inc. Announces Availability Of New Microdose Strips Oral Tabs For New California Recreational And Medical Cannabis Markets For 2018
03/01/2018
LOS ANGELES, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant for multiple [...]
ChemoCentryx to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
MOUNTAIN VIEW, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI ), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today [...]
Acer Therapeutics to Present at the Biotech Showcase™ 2018 Conference
03/01/2018
NEWTON, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER ), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra- [...]
Anthera Pharmaceuticals Announces Appointment of Patrick Murphy as Senior Vice President, Manufacturing
03/01/2018
HAYWARD, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced the appointment of Patrick Murphy as Senior Vice President, Manufacturing. Patrick brings over 35 years of [...]
Zosano Pharma Announces Notice of Allowance for a U.S. Patent Application Covering M207 as an Acute Treatment for Migraine
03/01/2018
FREMONT, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris
03/01/2018
REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt, M.D., a vascular [...]
Orion Corporation: Managers' transactions - Ylppö Jukka
03/01/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 03 JANUARY 2018 at 15.10 EET Orion Corporation: Managers' transactions - Ylppö Jukka Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors
03/01/2018
Current Chairman, David Drutz, M.D., remains Chairman of Compensation Committee and Member of the Board GAITHERSBURG, Md., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage [...]
Diffusion Pharmaceuticals to Present at the 10th Annual Biotech Showcase™ Conference
03/01/2018
CHARLOTTESVILLE, Va., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN ) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of [...]
Jounce Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
03/01/2018
CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
BioSig Technologies Appoints New Chief Financial Officer to Facilitate Growth Trajectory
03/01/2018
Santa Monica, CA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
ClearCorrect’s Flex and Unlimited pricing now available in Canada
03/01/2018
ROUND ROCK, Texas, Jan. 03, 2018 (GLOBE NEWSWIRE) -- ClearCorrect, LLC, a leading manufacturer of clear aligners, released their Flex ™ and Unlimited ™ pricing options to dentists and orthodontists in Canada on January [...]
Foamix Names Mr. David Domzalski as a Member of the Board of Foamix Pharmaceuticals
03/01/2018
REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ) (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Albireo Announces Royalty Monetization Agreement with HealthCare Royalty Partners for Elobixibat in Japan
03/01/2018
— Albireo subsidiary eligible to receive up to $60 million under agreement — — Decision on Japanese New Drug Application for elobixibat expected in first half of 2018 — BOSTON, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Albireo [...]
BeyondSpring Appoints Life Sciences Veteran Patrick Fabbio to Board of Directors as an Independent Member
03/01/2018
NEW YORK, Jan. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical stage biopharmaceutical company focused on the development and commercialization of innovative cancer therapies, today [...]
PositiveID’s ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11th
03/01/2018
Seed Central Showcase facilitates research collaboration between the seed and agbiotech industry and UC Davis to bring science to market faster Kimothy Smith, DVM, EVP and Chief Science Officer of ExcitePCR, will [...]

Pages